Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ex-GSK China researchers hit back

This article was originally published in Scrip

Executive Summary

The Chinese GlaxoSmithKline scientist who resigned in relation to alleged "misrepresentation of data" in a leading science journal has claimed not only that the data were authentic and reproducible but has also suggested that the internal investigation by the pharma firm may have been unbalanced.

You may also be interested in...



Deal Watch: Taking Care Of Business Before J.P. Morgan

Under Momenta/CSL autoimmune partnership, Momenta can opt in to co-development or commercialization on recombinant Fc receptor modulator or just earn a revenue stream from CSL’s efforts with the preclinical candidate. Pieris and Servier sign broad-based immuno-oncology collaboration, while Arena hands off the disappointing Belviq to Eisai.

Latest Commission Charts Show How Pandemic Is Stalling New Notified Body Appointments

Despite the urgency to have many more notified bodies designated under the MDR and IVDR, COVID-19 fall-out has resulted in a hiatus in their appointment, Commission figures show.

People On The Move: Appointments At RB, GSCF And CMDh

Reckitt hires chief digital officer from Nestlé and shakes up Australia leadership; GSCF names Bayer's Schipper as chair; and Europe's CMDh appoints a new chair.

Topics

Related Companies

UsernamePublicRestriction

Register

OM011995

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel